PDS Biotechnology Corp — Director's Dealing 2019

Mar 26, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2019-03-15

Reporting Person: Bloomquist DeLyle W (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	180918	Direct
Common Stock	605023	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock Warrant (Right to Buy)	$9.87	2023-12-21	Common Stock (15957)		Direct
Stock Option (Right to Buy)	$9.04	2029-03-14	Common Stock (11218)		Direct

Footnotes

F1: Mr. Bloomquist owns 80% of and is the manager of Asklepios Capital LLC and has voting and dispositive power with respect to these shares.

F2: Common Stock Warrant fully exercisable on date of issuance.

F3: Stock Option fully vested on date of grant.